Research indexJournal article
CRIXIVAN
ZURER
Chemical & Engineering News20 Jun 2005
NobleIDark:/48914/w1/20260522/F5BC813DDOI10.1021/cen-v083n025.p054
CRIXIVAN
ZURER · Chemical & Engineering News · 2005 · Subscription
NobleIDark:/48914/w1/20260522/F5BC813DDOI10.1021/cen-v083n025.p054
The full text is at the publisher
You can read the abstract here, or open it at the publisher.
Abstract
RETURN TO ISSUEPREVNewsNEXTCRIXIVANPAMELA ZURERCite this: Chem. Eng. News 2005, 83, 25, 54Publication Date (Print):June 20, 2005Publication History Published online14 November 2010Published inissue 20 June 2005https://pubs.acs.org/doi/10.1021/cen-v083n025.p054https://doi.org/10.1021/cen-v083n025.p054newsACS PublicationsCopyright © 2005 AMERICAN CHEMICAL SOCIETYArticle Views24Altmetric-Citations-LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access options SUBJECTS:Chemical synthesis,Inhibitors,Peptides and proteins,Pharmaceuticals,Pharmaceutics Get e-Alerts